Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Unraveling the mystery behind lower cancer risks in type 1 diabetes patients

29

Oct 2026

Unraveling the mystery behind lower cancer risks in type 1 diabetes patients

New research in The Journal of Immunology uncovers how high blood sugar (hyperglycemia) and type 1 diabetes (T1D) may protect against certain cancers like melanoma, breast and colon cancer. T1D has been associated with a decreased risk of certain cancers, but the exact reasons why have remained a mystery. New data from studies in mice, now shows that it could be due to changes in immune cells, called T cells, caused by hyperglycemia.

Insights into enzyme selectivity open new pathways for pharmaceutical synthesis

29

Oct 2026

Insights into enzyme selectivity open new pathways for pharmaceutical synthesis

Enzymes are the molecular tools of life. They accelerate chemical reactions and are able to distinguish very precisely between molecules that are similar to one another. The high selectivity of many enzymes is key to the production of important medicines such as penicillin and cyclosporine. But how did enzymes develop this ability to distinguish between similar chemical functionalities with such precision.

Ancient protein model shows early steps in energy metabolism

29

Oct 2026

Ancient protein model shows early steps in energy metabolism

Researchers in Japan engineered ancestral nucleoside diphosphate kinase variants with restricted amino acid repertoires to explore alternative catalytic functions. One variant, Arc1-12KR, retained its protein fold despite lacking catalytic histidine and unexpectedly converted two ADP molecules into ATP and AMP. The findings reveal alternative catalytic potential in simplified proteins and offer clues to possible routes of energy metabolism during early protein evolution.

New microscopy platform enables deeper brain imaging without tissue damage

28

Oct 2026

New microscopy platform enables deeper brain imaging without tissue damage

As light travels deeper into the brain, it scatters. Three-photon microscopy, the current state of the art, reduces the resulting background fluorescence and can, in principle, image much deeper than earlier techniques-but to do that, it uses average laser power limits that cause overheating and damage living tissue.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Mercury Pharmaceuticals
Mercury Pharmaceuticals

Why Us?

KNOWLEDGE OF RESEARCH ENVIRONMENT

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.

UNDERSTANDING INDUSTRIAL NEEDS

Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.

FOCUSED PROJECT MANAGEMENT

Smart approach to project management that helps speed up development stages and decision making.

INVESTMENT CAPABILITY

Availability of own investment up to 2m€ per project allows us to reach the next value milestone.